A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

Emily J Erbelding; Diane J Post; Erik J Stemmy; Paul C Roberts; Alison Deckhut Augustine; Stacy Ferguson; Catharine I Paules; Barney S Graham; Anthony S Fauci

doi:10.1093/infdis/jiy103

A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases

J Infect Dis. 2018 Jul 2;218(3):347-354. doi: 10.1093/infdis/jiy103.

Authors

Emily J Erbelding^{1

2}, Diane J Post^{1

2}, Erik J Stemmy^{1

2}, Paul C Roberts^{1

2}, Alison Deckhut Augustine^{1

3}, Stacy Ferguson^{1

3}, Catharine I Paules¹, Barney S Graham^{1

4}, Anthony S Fauci¹

Affiliations

¹ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
² Division of Microbiology and Infectious Diseases.
³ Division of Allergy, Immunology, and Transplantation.
⁴ Vaccine Research Center.

Abstract

A priority for the National Institute of Allergy and Infectious Diseases is development of a universal influenza vaccine providing durable protection against multiple influenza strains. NIAID will use this strategic plan as a foundation for future investments in influenza research.

MeSH terms

Animals
Biomedical Research / trends
Humans
Influenza Vaccines / immunology*
Influenza Vaccines / isolation & purification*
Influenza, Human / prevention & control*
Influenza, Human / virology
National Institute of Allergy and Infectious Diseases (U.S.)
United States
Zoonoses / prevention & control*
Zoonoses / virology

Substances

Influenza Vaccines